AzTrials
AzTrials

Cerebral PalsyNCT02391324

Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy

A study testing Lokomat (LOK), Gait focused physical therapy (fPT) and LOK + fPT in people with Cerebral Palsy, run by University of Alberta at 3 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Robot assisted gait training is seen as a promising intervention for improving the walking abilities of children with cerebral palsy, but research to support its effectiveness compared to best practice physical therapy is lacking. Read more about this study

Who is it for?
Ages 5 to 18 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Lokomat (LOK), Gait focused physical therapy (fPT) and LOK + fPT
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
68 participants
Where
3 sitesin 2 countries
Study dates
Jan 2016to 31 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Diagnosis of CP (any type), GMFCS Levels II and III
  • Able to follow GMFM testing instructions, and to participate in a minimum of 30 minutes of active PT (as judged by the child's PT or physician if not followed by a PT)
  • Able to reliably signal pain, fear and discomfort using verbal or nonverbal signals
  • Passive range of motion (ROM) of hips and knees within minimum range requirement for LOK (hip and knee flexion contracture < 10 degrees, and knee valgus < 40 degrees).
  • Parent/child agrees to attend 16 study intervention sessions (given within two 10-week periods), a LOK fitting/acclimatization session or fPT acclimatization session and the three assessment sessions during the course of the study.
  • Parent agrees to contact of their primary PT (if not already involved by parent in the screening process) and their paediatrician or physiatrist to confirm eligibility.
  • Parent agrees that regular PT (and other gross motor mobility therapies such as conductive education and MEDEK) will be discontinued from the time of the baseline assessment through the 8 to 10 weeks of the active intervention or control group. Note that home programs such as stretching and strengthening and treadmill and exercise bike riding (no more than 10 minutes total per day) will be permitted in all groups.

Who cannot join

  • Botulinum Toxin injection within the past 4 months or planned within the next 6 months
  • Fixed knee contracture > 10 degrees, knee valgus >40 degrees such that orthosis will not be adaptable to lower limbs.
  • Hip instability/subluxation as demonstrated by a migration percentage > 45%
  • Orthopaedic surgery (soft tissue releases) within the last 9 months, or lower limb bony surgery within the last 18 months
  • Severe spasticity may be a contraindication as determined in Lokomat trial session using L-FORCE assessment.
  • Any weightbearing restrictions.
Show all 9Show fewer
  • Seizure disorder unless fully controlled by medication and no evidence of seizure in the last 12 months and physician provides singed approval to enter the study
  • Open skin lesions or vascular disorder of lower extremities
  • Not able to co-operate or be positioned adequately within the LOK as shown during the fitting/acclimatisation session. -

Trial locations and contacts

3 sites in 2 countries.

3 sites in 2 countries

Canada2 sites
  • University of Alberta

    Edmonton, Alberta, T6G 2G4

  • Holland Bloorview Kids Rehabilitation Hospital

    Toronto, Ontario, M4G 1R8

Other trials in Canada

United States1 site
  • Shirley Ryan AbilityLab

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: Evaluation of the Effectiveness of Robotic Gait Training and Gait-focused Physical Therapy Programs for Children and Youth With Cerebral Palsy: A Mixed Methods Randomized Controlled Trial

Robot assisted gait training is seen as a promising intervention for improving the walking abilities of children with cerebral palsy, but research to support its effectiveness compared to best practice physical therapy is lacking. This research consists of a randomized controlled trial (RCT) and a qualitative descriptive study that is linked with the RCT. The goal of the RCT is to compare: 1) a walking training program with the Lokomat® robotic device (LOK), 2) a functional physical therapy program (fPT) that includes activities to enhance balance/co-ordination/endurance and advanced motor skills conducted over 'real ground', 3) a combined Lokomat® + functional physical therapy (LOK+fPT) program, and 4) a regular maintenance therapy condition (CONT) for ambulatory children and youth with CP (aged 5- 18 years). The three intervention programs will consist of sixteen 50-minute sessions given twice weekly over 8 to 10 weeks. The primary objective of the RCT is to compare the four groups with respect to walking-related motor skills as measured by the Gross Motor Function Measure. The secondary objectives are to compare each intervention's impact on walking abilities, individualized goals, fitness, balance, physical activity levels, child's belief in ability to do physical activity, participation and quality of life. The investigators will also evaluate the extent of carryover or progress 3 months after the intervention. The qualitative part of the study will consist of interviews of children and parents after they have finished the study intervention. The information from the interviews will assist us with interpretation of the outcome results (areas of impact and amount of change) from the RCT. In particular, the interviews will 1) provide insight into their experiences with the trial interventions, 2) identify the mobility-related outcomes that are important to families and the factors that influence their preferences, and 3) explain the family values, experiences and contextual factors that influenced participation in the study. This research will provide information needed to allow clinicians and families to make informed choices about Lokomat therapy and physical therapy options in relation to their child's functional goals and abilities.

Read the detailed description

Cerebral palsy (CP) is the most common cause of childhood physical disability, affecting 2.0-2.5 in 1000 children. CP represents a group of disorders of movement and posture with impairments (e.g., muscle weakness, decreased selective motor control, alterations in muscle tone, and impairment of postural control) that collectively affect functional mobility. About 65% of children/youth with CP use minimal or no assistive devices (leg braces, walkers, and/or wheelchairs) to walk (i.e., Gross Motor Function Classification System (GMFCS) Levels I and II) while children in GMFCS Levels III - V require varying degrees of bracing, walkers and other walking devices, wheelchairs, or assistance from others for mobility.

Robotic Assisted Gait training devices are increasingly used with children with CP to improve their gait related motor skills. The Lokomat® (LOK) is a commercially available robot assisted gait training system that uses robotics to simulate walking. It facilitates inter-limb co-ordination and gait cycle timing and provides variable degrees of body weight support and guidance.

This study represents the first adequately powered RCT to evaluate the effectiveness of robot assisted gait training for children with CP. The qualitative aspect will give contextual information to assist with interpretation of the RCT and provide valuable information about families' experiences with the interventions.

The research questions for this study are:

  1. What is the comparative effectiveness of robot assisted gait training (LOK) and fPT program for improving gait related motor skills of ambulatory children and youth with CP? ii) Does combining LOK and fPT result in greater improvements in gait related motor skills of ambulatory children and youth with CP than robot assisted gait training or fPT alone? iii) What are families' experiences with trial participation and what implications do they have for interpretation of the quantitative results and the use of robot assisted gait training and fPT in clinical settings?

Methods This trial is a concurrent, mixed methods study. Specifically, the quantitative arm is a multi-centre RCT with four groups (22 factorial design, i.e., LOK absent/present, fPT absent/present) with two periods of post-intervention assessments (immediate and 3 months later). The RCT is linked with an interpretive descriptive qualitative study arm. The three study sites are Holland Bloorview (Toronto, Ontario, Canada), Glenrose Rehabilitation Hospital (Edmonton, Alberta, Canada) and Rehabilitation Institute of Chicago (Chicago, IL).

Participants - Children aged 5-18 with CP, GMFCS levels II and III. Inclusion/Exclusion criteria included in protocol in documents section.

Randomization - Following the baseline assessment, participants will be randomly allocated to one of the four groups using computer-generated random sequence.

Blinding Physical therapist assessors and data analysts will be blinded to group allocation.

TreatmentThere are three intervention groups: 1) LOK, 2) LOK + fPT, 3) fPT, and 4) one maintenance therapy control (CONT) arm. All three intervention groups will receive two 50-minute sessions per week, conducted over 8 -10 weeks. Children in all four groups can continue to participate in 'maintenance therapy'. Each child will be assigned to a treatment team of two trained PTs who will share responsibility for the 8 to 10 week intervention phase.

LOK - two 50-minute sessions on the Lokomat® per week. The study manualized LOK walking protocol provides methods for progressing/tracking including a 5-minute over ground walking session after the LOK to facilitate transfer of motor learning from the Lokomat to usual walking devices.

fPT Participants will Two 50-minute sessions per week. The manualized motor-learning based protocol forms the basis for this intervention. Its focus is on balance and multi-plane gait-based motor skills.

LOK + fPT group protocol: Participants will alternate between LOK and one fPT session per week for the duration of the 8 to 10 week intervention phase.

Monitoring co-interventionsMaintenance therapies such as home stretching and strengthening routines can be continued for all 4 groups throughout the study because these therapies have questionable efficacy, and will likely be equally used across all four groups as they are common PT recommendations.

Outcomes - All study outcomes will be measured pre-/post-intervention (< 10 days pre-intervention and post-completion), and at 3m follow-up (+/- 10 day window) by trained physical therapists. Data will be entered into REDCap.

Primary Outcome - The primary outcome measure is the Gross Motor Function Measure-66 (GMFM-66 Dimensions D (Stand) and E (Walk/Run/Jump).

Secondary Outcomes - Secondary outcomes are measures of walking capacity(6 minute walk test) fitness (adapted shuttle run test), balance (Pediatric Berg Balance Scale, Quality Function Measure (FM), and Activities Balance Confidence Scale), functional abilities (PEDI-CAT), physical activity levels (accelerometry), participation (Participation and Environment Measure for Children and Youth), physical activity self-efficacy (Self-Efficacy for Physical Activity), individualized goal attainment (Canadian Occupational Performance Measure (COPM) and Goal Attainment Scaling), and quality of life (KidScreen and Students' Life Satisfaction Scale).

Statistical Analysis - Data will be described (e.g., means, standard deviations, frequencies) for each intervention group and each stratification variable. Mixed-effects multiple linear regression models will be developed for each outcome with centre as a random effect, centre by intervention as an interaction (to assess centre effect), and other important variables (e.g., age and GMFCS level) as covariates. All main analyses will be based on intent-to-treat with secondary analyses of those with >80% adherence to their intervention.

Qualitative Component

The three objectives of the concurrent qualitative component are to explicate:

  1. Child and parent experiences with the trial interventions and the values and previous experiences that shape their perceptions.
  2. The mobility related outcomes that are important to families and factors that influence these views.
  3. Child and family values, experiences and contextual factors that influenced participation in the trial, including the follow-up period.

Design Interpretive description

Sample selection- The investigators will invite a subset of child-parent dyads from each of the active interventions in the RCT. In addition, parents of children who were eligible but declined to participate in the RCT will be invited to participate in the qualitative component to address objective #3. The estimated sample size is (i.e., 6 child/parent dyads plus 3 parents from each site).

Data Collection - Parents will participate in 45-60 minute semi-structured, individual interviews conducted by one member of the research team. Participating parents of children in the RCT will be interviewed at 2 points within the trial: i) after completion of the COPM and prior to receiving the intervention, and ii) within one month of intervention completion.

Children from the RCT will participate in individual interviews at the end of their LOK/fPT intervention. A customizable "tool box" of age-appropriate child-friendly techniques including photographs and comic captioning, vignettes, and sentence starters will be used in a 30-45 minute semi-structured interview with the child without the parent present.

Data Management and Analysis Interviews will be digitally audio-recorded, transcribed verbatim by a professional transcriptionist, de-identified and imported into NVivo for data management. Two researchers will collaboratively identify general coding categories. The researchers will meet to establish consensus on the coding.

Conditions
Cerebral Palsy
Being tested
Lokomat (LOK), Gait focused physical therapy (fPT), LOK + fPT
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lokomat (LOK)Procedure or surgery

    Also called Robotic Gait Training

    Physical therapy provided using a robotic gait training system (Lokomat).

  • Gait focused physical therapy (fPT)Procedure or surgery

    Overground physical therapy focussed on enhancing gait related motor skills

  • LOK + fPTProcedure or surgery

    A combination of robotic gait training and gait focussed functional physical therapy.

Study groups in NCT02391324
Study groupRoleWhat they receive
Lokomat (LOK)ExperimentalTwo 50-minute sessions per week. The manualized LOK walking protocol provides methods for progressing/tracking including a 5-minute overground walking session after the LOK to facilitate transfer of motor learning from the LOK to usual walking devices. The goal-based LOK program uses a standardized approach to progressing LOK body weight and guidance support and includes upper body activities while walking to encourage dual tasking and improved posture, and motor imagery practice.
Receives: Procedure: Lokomat (LOK)
Gait focused physical therapy (fPT)ExperimentalTwo 50-minute sessions per week. Each weekly fPT session consists of 50 minutes of active treatment, a 'dose' equivalent to time spent in active treatment in the LOK arm. Techniques that focus on body structure changes will be not be permitted (e.g., inhibitive casting, kinesiotaping, functional electrical stimulation).
Receives: Procedure: Gait focused physical therapy (fPT)
LOK + fPTExperimentalTwo 50-minute sessions per week. Children will receive both the LOK and the fPT protocols (content as described above for each) for the duration of the 8 to 10 week intervention phase. These will be given as two sessions of LOK one week alternating with two sessions of fPT the next week. The fPT will build on motor learning principles because the activities will allow the child to practice motor skills in a variety of different activities. Techniques focusing on body structure changes will be prohibited.
Receives: Procedure: LOK + fPT
Maintenance therapyNo interventionConsists of maintenance therapy and a weekly email from the centre's research assistant to monitor any co-interventions. Maintenance may include range of motion/stretching and basic isometric strength home program as well as up to 10 minutes per day of exercise bicycle or treadmill or general walking practice.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in gross motor abilities using the Gross Motor Function Measure (GMFM-66) from 0-8 and 0-20 weeks

    A standardized measure of gross motor function for children with cerebral palsy

    Measured: Baseline, 8 weeks, 20 weeks

Secondary outcomes (13)
  1. Change in walking distance using the 6-Minute walk test from 0-8 and 0-20 weeks

    Distance walked in 6 minutes

    Measured: Baseline, 8 weeks, 20 weeks

  2. Change in individual goal attainment using the Canadian Occupational Performance Measure (COPM) performance ratings from 0-8 and 0-20 weeks

    Individualized goal setting tool and outcome measure (ratings of performance and satisfaction with performance)

    Measured: Baseline, 8 weeks, 20 weeks

  3. Change in individual goal attainment using Goal Attainment Scaling (GAS) from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  4. Change in anaerobic capacity using the Adapted Shuttle Run Test from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  5. Change in Pediatric Berg Balance Scale from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  6. Change in Quality FM from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  7. Change in confidence in performing ambulatory abilities as measured by the Activities Balance Confidence Scale from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  8. Change in functional abilities as measured by the PEDI-CAT from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  9. Change in # of steps/day from 0-8 and 0-20 weeks as measured with an accelerometer.

    Measured: Baseline, 8 weeks, 20 weeks

  10. Change in self-efficacy for physical activity as measured by the Physical Activity Self-efficacy scale

    Change in Self-efficacy for Physical Activity score from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  11. Change in the participation measured using the Participation and Environment Measure for Children and Youth (PEM-CY) from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

  12. Change in quality of life using the Kidscreen from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks-up

  13. Change in quality of life using the Life Satisfaction Scale from 0-8 and 0-20 weeks

    Measured: Baseline, 8 weeks, 20 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2015 (estimated)
  2. Study startJan 2016
  3. Primary completion31 Mar 2025
  4. Study completion31 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
68 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02391324
Sponsor's protocol ID
RES0022460
Status last verified
Apr 2026
First submitted
6 Mar 2015
Last updated
4 May 2026
Results posted
No
Data monitoring committee
Yes

Publications

  • Wiart L, Rosychuk RJ, Wright FV. Evaluation of the effectiveness of robotic gait training and gait-focused physical therapy programs for children and youth with cerebral palsy: a mixed methods RCT. BMC Neurol. 2016 Jun 2;16:86. doi: 10.1186/s12883-016-0582-7.

    PubMed 27255908

Questions about this trial

What is this clinical trial studying?

A study testing Lokomat (LOK), Gait focused physical therapy (fPT) and LOK + fPT in people with Cerebral Palsy, run by University of Alberta at 3 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Canada, United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in gross motor abilities using the Gross Motor Function Measure (GMFM-66) from 0-8 and 0-20 weeks (time frame: Baseline, 8 weeks, 20 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02391324, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in